Hengkang Medical Valuation
| 002219 Stock | 2.70 0.02 0.75% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Hengkang Medical retains a regular Real Value of USD2.57 per share. The prevalent price of the firm is USD2.7. Our model calculates the value of Hengkang Medical from evaluating the firm fundamentals such as Current Valuation of 10.42 B, return on asset of 0.0212, and Return On Equity of 0.0262 as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 3.9785 | Enterprise Value 10.4 B | Enterprise Value Ebitda 60.9119 | Price Sales 2.4448 | Trailing PE 270 |
Overvalued
Today
Please note that Hengkang Medical's price fluctuation is very risky at this time. Calculation of the real value of Hengkang Medical is based on 3 months time horizon. Increasing Hengkang Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Hengkang Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Hengkang Stock. However, Hengkang Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.7 | Real 2.57 | Hype 2.7 | Naive 2.53 |
The real value of Hengkang Stock, also known as its intrinsic value, is the underlying worth of Hengkang Medical Company, which is reflected in its stock price. It is based on Hengkang Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Hengkang Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Hengkang Medical Group helps investors to forecast how Hengkang stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Hengkang Medical more accurately as focusing exclusively on Hengkang Medical's fundamentals will not take into account other important factors: Hengkang Medical Cash |
|
Hengkang Medical Total Value Analysis
Hengkang Medical Group is presently forecasted to have takeover price of 10.42 B with market capitalization of 9.2 B, debt of 716.49 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Hengkang Medical fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
10.42 B | 9.2 B | 716.49 M |
Hengkang Medical Investor Information
About 52.0% of the company shares are owned by insiders or employees . The book value of Hengkang Medical was presently reported as 0.68. The company last dividend was issued on the 28th of February 2014. Hengkang Medical had 25:10 split on the 28th of October 2015. Based on the analysis of Hengkang Medical's profitability, liquidity, and operating efficiency, Hengkang Medical Group is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Hengkang Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Hengkang Medical has an asset utilization ratio of 59.05 percent. This suggests that the Company is making USD0.59 for each dollar of assets. An increasing asset utilization means that Hengkang Medical Group is more efficient with each dollar of assets it utilizes for everyday operations.Hengkang Medical Ownership Allocation
Hengkang Medical Group has a total of 3.41 Billion outstanding shares. Hengkang Medical secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Hengkang Medical Profitability Analysis
The company reported the revenue of 3.59 B. Net Income was 30.78 M with profit before overhead, payroll, taxes, and interest of 992.37 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Hengkang Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Hengkang Medical and how it compares across the competition.
About Hengkang Medical Valuation
The stock valuation mechanism determines Hengkang Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Hengkang Medical. We calculate exposure to Hengkang Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Hengkang Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 1.1 B | 1 B |
Complementary Tools for Hengkang Stock analysis
When running Hengkang Medical's price analysis, check to measure Hengkang Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hengkang Medical is operating at the current time. Most of Hengkang Medical's value examination focuses on studying past and present price action to predict the probability of Hengkang Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hengkang Medical's price. Additionally, you may evaluate how the addition of Hengkang Medical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |